Sepracor starts (S)-zopiclone Phase III

SEPR began Phase III testing of its (S)-zopiclone, a single-isomer form of racemic zopiclone non-benzodiazepine cyclopyrrolone hypnotic to treat insomnia. A second Phase III trial is expected to begin...